We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Pacific Biosciences of California Inc | NASDAQ:PACB | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.08 | 4.37% | 1.91 | 1.86 | 1.91 | 1.98 | 1.81 | 1.82 | 7,695,850 | 00:59:23 |
From May 2019 to May 2024
By Josh Beckerman
Pacific Biosciences of California Inc. (PACB) shares fell 9% after hours to $4.85 as the Federal Trade Commission said it is challenging the company's $1.2 billion sale to Illumina Inc. (ILMN).
The deal was disclosed in November 2018. In January, Pacific Biosciences said the FTC requested additional information on the transaction.
Write to Josh Beckerman at josh.beckerman@wsj.com
(END) Dow Jones Newswires
December 17, 2019 17:17 ET (22:17 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
1 Year Pacific Biosciences of C... Chart |
1 Month Pacific Biosciences of C... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
